INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 454m ago
HOUSE PTR54m ago
SEC 13F54m ago
ROBINHOOD CHAIN54m ago
EB
Corporate insider

Edris Badreddin

DirectorCIK 0001786966

EDGAR filingsOpen in network
Disclosed transactions15
Buys / sells0 / 5
Max Insider Score26
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
11
EB
Edris BadreddinDirector
EWTXEdgewise Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$5,339
13.7K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Edgewise Therapeutics, Inc.Director · Jan 23, 2026
11
EB
Edris BadreddinDirector
EWTXEdgewise Therapeutics, Inc.
Option exercise · 10b5-1 plan
M
$11K
17.2K sh
Jan 21, 2026
Jan 23, 2026
traded Jan 21, 2026
+2d
SEC FORM 4

Evidence

7
EB
Edris BadreddinDirector
EWTXEdgewise Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$20K
10.5K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC FORM 4

Evidence

15
EB
Edris BadreddinDirector
EWTXEdgewise Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$403K
13.7K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC FORM 4

Evidence

15
EB
Edris BadreddinDirector
EWTXEdgewise Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$507K
17.2K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC FORM 4

Evidence

15
EB
Edris BadreddinDirector
EWTXEdgewise Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$308K
10.5K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC FORM 4

Evidence

26
EB
Edris BadreddinDirector
EWTXEdgewise Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1.96M
66.5K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC FORM 4

Evidence

0
EB
Edris BadreddinDirector
EWTXEdgewise Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
10.5K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC FORM 4

Evidence

0
EB
Edris BadreddinDirector
EWTXEdgewise Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
66.5K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC FORM 4

Evidence

0
EB
Edris BadreddinDirector
EWTXEdgewise Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
7,605 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC FORM 4

Evidence

0
EB
Edris BadreddinDirector
EWTXEdgewise Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
17.2K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC FORM 4

Evidence

0
EB
Edris BadreddinDirector
EWTXEdgewise Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
13.7K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC FORM 4

Evidence

12
EB
Edris BadreddinDirector
EWTXEdgewise Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$224K
7,605 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC FORM 4

Evidence

3
EB
Edris BadreddinDirector
EWTXEdgewise Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$5,400
7,605 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC FORM 4

Evidence

14
EB
Edris BadreddinDirector
EWTXEdgewise Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$128K
66.5K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC FORM 4

Evidence